Bone marrow concentrate and bovine bone mineral for sinus floor augmentation: a controlled, randomized, single-blinded clinical and histological trial--per-protocol analysis

• Published in: Tissue engineering. Part A Vol. 17; no. 17-18; p. 2187
• Main Authors: Sauerbier, Sebastian, Rickert, Daniela, Gutwald, Ralf, Nagursky, Heiner, Oshima, Toshiyuki, Xavier, Samuel P, Christmann, Johannes, Kurz, Patrick, Menne, Dieter, Vissink, Arjan, Raghoebar, Gerry, Schmelzeisen, Rainer, Wagner, Wilfried, Koch, Felix P
• Format: Journal Article
• Language: English
• Published: United States 01-09-2011
• Subjects: Adult; Aged; Animals; Bone Marrow - metabolism; Bone Regeneration - physiology; Bone Substitutes - therapeutic use; Bone Transplantation - methods; Cattle; Female; Humans; Male; Maxillary Sinus - surgery; Middle Aged; Osteogenesis - physiology; Single-Blind Method; Sinus Floor Augmentation - methods
• ISSN: 1937-335X
• DOI: 10.1089/ten.tea.2010.0516

The purpose of this work was to evaluate the potential of substituting autogenous bone (AB) by bone marrow aspirate concentrate (BMAC). Both AB and BMAC were tested in combination with a bovine bone mineral (BBM) for their ability of new bone formation (NBF) in a multicentric, randomized, controlled, clinical and histological noninferiority trial.
Forty-five severely atrophied maxillary sinus from 26 patients were evaluated in a partial cross-over design. As test arm, 34 sinus of 25 patients were augmented with BBM and BMAC containing mesenchymal stem cells. Eleven control sinus from 11 patients were augmented with a mixture of 70% BBM and 30% AB. Biopsies were obtained after a 3-4-month healing period at time of implant placement and histomorphometrically analyzed for NBF.
NBF was 14.3%±1.8% for the control and nonsignificantly lower (12.6%±1.7%) for the test (90% confidence interval: -4.6 to 1.2). Values for BBM (31.3%±2.7%) were significantly higher for the test compared with control (19.3%±2.5%) (p<0.0001). Nonmineralized tissue was lower by 3.3% in the test compared with control (57.6%; p=0.137).
NBF after 3-4 months is equivalent in sinus, augmented with BMAC and BBM or a mixture of AB and BBM. This technique could be an alternative for using autografts to stimulate bone formation.